IndieBio | Activity | F4IndieBio Activity
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Milestone
Portfolio company Prolific Machines reported a monoclonal antibody manufacturing productivity milestone using its light-controlled platform.
Prolific Machines
4 investments· APR 2026Show all
Investment
Participated in Fermeate's $2M Seed round for optogenetics-enabled precision fermentation.
Fermeate
Investment
Aspect Aerospace raises $2.4M for single-board satellites for space-based environmental monitoring.
Aspect Aerospace
Investment
HexemBio raises $10.4M Seed for stem cell rejuvenation therapies.
HexemBio
Investment
Unspun raises $40M for low-waste weaving machines and factory expansion.
unspun
News
SOSV announced that IndieBio is now operating as SOSV SF and SOSV NY to reflect a broader deep tech remit beyond biology.
IndieBio rebrand to SOSV SF and SOSV NY
News
IndieBio rebranded to SOSV NY and SOSV SF to reflect expanded focus beyond biotech into broader deep tech.
Rebranded to SOSV NY and SOSV SF
Exit
Portfolio company Catalog acquired by Biomemory.
Catalog
4 investments· AUG 2025 – MAR 2026Show all
Investment
TippingPoint raises $4.5M Seed to target epigenetic mechanisms in pediatric brain cancer.
TippingPoint
Investment
Cocoon raises $15M Series A for critical cement substitute materials.
Cocoon
Investment
Cauldron raises $13.25M A2 to advance hyper fermentation biomanufacturing.
Cauldron
Investment
Sava announces $19M Series A led by Balderton Capital.
Sava